Stock Fundamentals

Company Information

Company Name
GlaxoSmithKline PLC ADR
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
ISIN: US37733W2044
CIK: 0001131399
CUSIP: 37733W105
Currency: USD
Full Time Employees: 66,841
Phone: 44 20 8047 5000
Fiscal Year End: December
IPO Date: Jul 09, 1986
Description:

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

Address:

79 New Oxford Street, London, United Kingdom, WC1A 1DG

Directors & Officers

Name Title Year Born
Ms. Julie Belita Brown A.C.A. CFO & Executive Director 1962
Ms. Emma Natasha Walmsley Executive Officer 1969
Dr. Jesse L. Goodman M.D., M.P.H. Scientific & Medical Expert 1951
Mr. Luke Victor Miels CEO & Director 1974
Ms. Shobie Ramakrishnan Chief Digital & Technology Officer 1971
Mr. Tony Wood Chief Scientific Officer and Head of R&D NA
Mr. Constantin Fest Senior VP & Head of Investor Relations 1977
Mr. James Ford Senior VP and Group General Counsel of Legal & Compliance NA
Mr. David Simon Redfern BSc (Hons), CA President of Corporate Development 1966
Ms. Roanne Parry Chief People Officer 1974

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 11, 2025 Plc Gsk N/A Purchase 1.47M $19.00 $27.93M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 67.66M Mar 31, 2026 3.37% $0.20 0.28%
Dodge & Cox 58.66M Mar 31, 2026 2.92% $1.78 -14.38%
Fisher Asset Management, LLC 34.52M Mar 31, 2026 1.72% $0.65 4.00%
PRIMECAP Management Company 25.20M Mar 31, 2026 1.26% $1.10 0.30%
Acadian Asset Management LLC 11.80M Mar 31, 2026 0.59% $0.92 1,169.89%
Wellington Management Company LLP 11.72M Mar 31, 2026 0.58% $0.12 -6.69%
Morgan Stanley - Brokerage Accounts 11.03M Mar 31, 2026 0.55% $0.04 89.25%
The Goldman Sachs Group Inc 9.59M Mar 31, 2026 0.48% $0.06 32.41%
JTC Employer Solutions Trustee Ltd 9.04M Mar 31, 2026 0.45% $41.69 -37.33%
Royal Bank of Canada 7.51M Mar 31, 2026 0.37% $0.07 -11.48%
T. Rowe Price Associates, Inc. 7.32M Mar 31, 2026 0.37% $0.05 -7.24%
State Street Corp 6.00M Mar 31, 2026 0.30% $0.01 -4.07%
Holocene Advisors, LP 5.52M Mar 31, 2026 0.28% $0.73 -32.01%
Mondrian Investment Partners Ltd 4.99M Mar 31, 2026 0.25% $4.12 -14.11%
Bank of Montreal 4.64M Mar 31, 2026 0.23% $0.10 78.46%
BMO Capital Markets Corp. 4.64M Mar 31, 2026 0.23% $0.10 78.46%
BlackRock Inc 3.55M Mar 31, 2026 0.18% $0.00 95.73%
Grantham, Mayo, Van Otterloo & Co., LLC 3.52M Mar 31, 2026 0.18% $0.50 0.95%
Hotchkis & Wiley Capital Management LLC 3.48M Mar 31, 2026 0.17% $0.59 -4.81%
Equity Investment Corp 3.22M Mar 31, 2026 0.16% $3.48 -21.64%

Shares Statistics

Shares Outstanding: 2.01B
Shares Float: 3.89B
% Insiders: 6.00%
% Institutions: 1,875.90%
Short % Float: 0.68%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Dodge & Cox Stock I 42.98M 2.14% ▼ 14.99% Mar 31, 2026
2 Vanguard PRIMECAP Inv 18.15M 0.90% ▲ 0.03% Mar 31, 2026
3 Vanguard Wellington Inv 9.86M 0.49% ▼ 6.70% Mar 31, 2026
4 Strategic Advisers Fidelity US TtlStk 7.77M 0.39% ▲ 0.00% Mar 31, 2026
5 Fidelity Series Large Cap Stock 4.50M 0.22% ▲ 0.00% Mar 31, 2026
6 Dodge & Cox Balanced I 4.24M 0.21% ▼ 13.89% Mar 31, 2026
7 Dodge & Cox Balanced Composite 4.24M 0.21% ▼ 13.89% Mar 31, 2026
8 Fidelity Series Value Discovery 4.18M 0.21% ▼ 0.64% Mar 31, 2026
9 T. Rowe Price International Val Eq Tr- A 3.71M 0.18% ▼ 9.76% Mar 31, 2026
10 Vanguard PRIMECAP Core Inv 3.54M 0.18% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $119.25B
Trailing P/E: 13.02
Forward P/E: 10.44

Financial Highlights

Market Cap: $99.70B
EBITDA: $11.43B
P/E Ratio: $13.02
PEG Ratio: $9.40
Book Value: $11.95
Dividend/Share: $0.67
Dividend Yield: 3.62%
Earnings/Share: $3.82
Profit Margin: 17.78%
Operating Margin: 36.28%
ROA (TTM): 10.02%
ROE (TTM): 40.91%
Revenue (TTM): $32.78B
Revenue/Share (TTM): $16.25
Earnings Growth (YOY): 8.40%
Revenue Growth (YOY): 1.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.82x 1.04x 0.74x 12.14x 1.64x
2024-12-31 0.78x 1.17x 0.78x 6.11x 2.41x
2023-12-31 0.88x 1.04x 0.78x 8.70x 1.95x
2022-12-31 0.91x 1.98x 0.83x 7.52x 2.44x
2021-12-31 0.79x 1.25x 0.73x 5.56x 3.92x
2020-12-31 0.91x 1.43x 0.74x 6.70x 3.54x
2019-12-31 0.81x 2.10x 0.77x 7.63x 3.44x
2018-12-31 0.75x 5.97x 0.94x 7.37x 3.54x
2017-12-31 0.60x 4.89x 0.94x 5.57x 2.76x
2016-12-31 0.88x 3.78x 0.92x 3.53x 4.23x
2015-12-31 1.24x 1.87x 0.83x 13.64x 1.29x
2014-12-31 1.10x 5.60x 0.88x 5.17x 5.36x
2013-12-31 1.11x 4.06x 0.81x 9.16x 3.23x
2012-12-31 0.99x 4.73x 0.84x 9.93x 3.12x
2011-12-31 1.08x 2.70x 0.79x 10.52x 2.19x
2010-12-31 1.27x 2.60x 0.77x 4.94x 4.11x
2009-12-31 1.45x 2.54x 0.75x 10.76x 2.48x
2008-12-31 1.72x 2.93x 0.79x 8.47x 2.66x
2007-12-31 1.32x 1.83x 0.68x 25.21x 1.90x
2006-12-31 1.51x 1.07x 0.62x 22.18x 1.15x
2005-12-31 1.39x 1.40x 0.72x 0.81x 8.09x
2004-12-31 1.26x 1.74x 0.74x 15.89x 1.51x
2003-12-31 1.47x 1.03x 0.65x 39.65x 1.10x
2002-12-31 1.22x 0.99x 0.67x 39.37x 1.00x
2001-12-31 1.06x 0.69x 0.62x 5.31x 0.75x
2000-12-31 1.24x 0.64x 0.59x 14.92x 0.69x
1999-12-31 1.16x 0.72x 0.69x 12.74x 0.70x
1998-12-31 1.33x 0.49x 0.70x 13.28x 0.41x
1997-12-31 1.24x 0.64x 0.78x 12.43x 0.36x
1996-12-31 1.05x 1.26x 0.85x 11.35x 0.42x
1995-12-31 0.78x 33.01x 0.97x 7.07x 0.92x
1994-12-31 1.18x 2.24x 0.93x N/A 0.52x
1993-12-31 2.18x 0.08x 0.35x 41.30x 0.19x
1992-12-31 2.02x 0.13x 0.38x 27.23x 0.31x
1991-12-31 2.11x 0.10x 0.36x 20.43x 0.22x
1990-12-31 1.79x 0.27x 0.43x 18.11x 0.58x
1989-12-31 2.04x 0.16x 0.38x 27.86x 0.32x
1988-12-31 2.64x 0.06x 0.33x 39.69x 0.13x
1987-12-31 2.28x 0.14x 0.37x 40.62x 0.27x
1986-12-31 2.33x 0.14x 0.38x 68.82x 0.24x
1985-12-31 2.18x 0.10x 0.39x 88.43x 0.16x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GSK.US!